GeneTex
United States (US)

delta Opioid receptor antibody

OPRD1-antibody-GTX71799-IHC-1_18121411_993.jpg

Cat No. GTX71799

Host Rabbit
Clonality Polyclonal
Isotype IgG
Application IHC-P, IHC
Reactivity Human
APPLICATION

Application Note

Immunohistochemistry with formalin fixed paraffin embedded tissues. Not tested for other uses. IHC-P: Use at a dilution of 1/100 - 1/200.

Calculated MW

40 kDa. ( Note )
PROPERTIES

Form

Liquid

Buffer

Phosphate buffered saline, pH 7.4 containing 0.01% sodium azide

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Concentration

1mg/ml(Please refer to the vial label for the specific concentration.)

Antigen Species

Human

Immunogen

Synthetic peptide - KLH conjugated

Purification

Immunogen affinity purified.
Peptide immunogen affinity column

Conjugation

Unconjugated

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET

Synonyms

OPRD

Background

OPRD1 is an Opioid Receptor that is involved in the control of anxiety, depression, and pain. It is a promising target in the therapy of mood-altering disorders and drug addiction. Delta and kappa opioid receptors function synergistically by forming heterodimers. OPRD1 expression has been reported primarily in the brain. High OPRD1 expression has been documented in the cortex, caudate, hippocampus, nucleus accumbens, and putamen; low OPRD1 expression has been identified in the cerebellum, hypothalamus, substantia nigra, and thalamus. OPRD1 expression is reduced in the putamen and amygdala of Alzheimer’s patients and in the putamen in Parkinson’s disease.

Database

Research Area

DATA IMAGES
OPRD1-antibody-GTX71799-IHC-1_18121411_993.jpg

GTX71799 IHC Image

Lymphocytes

Package List Price ($)
$ 319